The Guardian On the morning of 9 November, as the world awoke to the game-changing news that Pfizer’s coronavirus vaccine was more than 90% effective, Anthony Fauci sat for a triumphant 9am press conference. But he was not there to discuss Covid-19.
As head of the National Institute of Allergy and Infectious Diseases (NIAID) for 36 years, Fauci had been a major force behind a trial that had just proved that a long-acting injectable drug, cabotegravir, was highly effective at preventing women from contracting HIV.
“I wanted the world to see that with all due respect to the extraordinary stress and strain that we’re going through with Covid, HIV is still a very important disease,” Fauci told the Guardian.
Read More →
